Skip to main content
/
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.430
-0.190 (-4.11%)
At close: Mar 28, 2025, 4:00 PM
4.439
+0.009 (0.19%)
After-hours: Mar 28, 2025, 5:20 PM EDT

Aurora Cannabis Revenue

Aurora Cannabis had revenue of 88.20M CAD in the quarter ending December 31, 2024, with 37.01% growth. This brings the company's revenue in the last twelve months to 320.81M, up 20.72% year-over-year. In the fiscal year ending March 31, 2024, Aurora Cannabis had annual revenue of 270.28M with 20.77% growth.

Revenue (ttm)
320.81M CAD
Revenue Growth
+20.72%
P/S Ratio
1.14
Revenue / Employee
298,984 CAD
Employees
1,073
Market Cap
253.08M USD

Revenue Chart

Created with Highcharts 11.4.8Aurora Cannabis Revenue - Annual268.7M​268.7M245.3M​245.3M221.3M​221.3M223.8M​223.8M270.3M​270.3M20202021202220232024-50M100M150M200M250M
* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024270.28M46.48M20.77%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021245.25M-23.45M-8.73%
Jun 30, 2020268.70M23.17M9.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

ACB News

More News